Kaitlin Roberson

Kaitlin Roberson is a Vital graduate and co-founder and CEO of Cacti Therapeutics, a psychedelic biotech company developing novel therapies for chronic pain. She has a strong background in research and has worked extensively on trauma and chronic pain. Roberson is passionate about using psychedelics to improve human health and well-being. She is also a strong advocate for the responsible development and use of psychedelics in medicine.